CDW9 Navigating Career Transitions: Lessons Learned as a New PI

Program: Career Development Workshops
Translational Session
Monday, April 4, 2016: 9:00 AM-10:30 AM
Room 204 (BCEC)

Stephen R Hammes, MD, PhD, University of Rochester, Rochester, NY

Dr. Hammes graduated with a degree in Chemistry from Cornell University in 1985. He then received his MD/PhD from Duke University. Dr. Hammes then moved to the University of California in San Francisco (UCSF), where he completed an internship and residency in General Medicine, followed by a clinical and research fellowship in Endocrinology. In 1999, Dr. Hammes joined the faculty at the University of Texas Southwestern Medical Center in Dallas, where he was a W. W. Caruth Scholar in Biomedical Research and Co-Director of the Endocrinology Fellowship Program. He moved to the University of Rochester in 2009 to become the Louis S Wolk Distinguished Professor of Medicine and the Chief of the Division of Endocrinology and Metabolism. Dr. Hammes is also Director of the Endocrinology Fellowship Program at the University of Rochester Medical Center. Dr. Hammes is interested in ovarian development and function. His laboratory studies steroid synthesis and actions in the ovary, with a focus on the pathophysiology of Polycystic Ovarian Syndrome (PCOS). In addition, his lab studies androgen signaling in prostate cancer, focusing on nongenomic actions of androgens. Finally, Dr. Hammes has an interest in lymphangioleiomyomatosis (LAM), a rare lung tumor that affects almost exclusively women. Dr. Hammes is the Editor-in-Chief of the journal "Molecular Endocrinology” and has actively served on NIH study sections for many years.

Jennifer K Richer, PhD, University of Colorado, Aurora, CO

Dr. Jennifer Richer - Associate Professor in the Department of Pathology, University of Colorado Anschutz Medical Campus, obtained her doctorate from Colorado State University in the Pathology Department/Cell and Molecular Biology Program. She has been conducting research on nuclear hormone receptor action for over 20 years. The Richer lab focuses on steroid hormone receptor action in women’s cancers and differences between hormone-dependent versus independent disease. Dr. Richer is an active mentor of graduate students and fellows and is the 2015 recipient of the Graduate School Dean’s Mentoring Award and the BEST Faculty Sponsor Award. She serves on the Editorial Board for Breast Cancer Research and Hormones and Cancer. She has served on grant review panels for NIH Molecular and Cellular Endocrinology and Tumor Cell Biology study sections ad hoc, AACR, and the DOD Breast Cancer Research Program. Dr. Richer is co-chair of the 2016 Keystone Symposium on Nuclear Hormone Receptors. Endocrine Society Service: Dr. Richer has served a three year term on The Endocrine Society Annual Meeting Steering Committee and is currently on the Scientific and Educational Programs Core Committee and Women in Endocrinology Nominating Committee.

Marc J Tetel, PHD, Wellesley College, Wellesley, MA

Marc Tetel received his B.A. in Biological Sciences from Northwestern University. After taking some time to travel abroad, he entered a Ph.D. program in Neuroscience and Behavior at the University of Massachusetts, Amherst. Working with Dr. Jeff Blaustein, he studied how estradiol and progesterone act in the brain to regulate female reproductive behavior in rats. For his postdoctoral research, Dr. Tetel studied molecular mechanisms of progestin receptor action with Dr. Dean Edwards at the University of Colorado Health Sciences Center. During this post-doc in molecular endocrinology, Dr. TetelÂ’s research investigated the function of nuclear receptor coactivators in progestin receptor function. After working with a number of undergraduates during his graduate and post-doc training, Dr. Tetel decided he wanted a faculty position involving teaching and research with undergraduates at a selective liberal arts college. He is now the Class of 1966 Associate Professor in Neuroscience at Wellesley College and a member of the Biological Chemistry Program. Dr. Tetel’s lab studies molecular mechanisms of estrogen and progestin receptor action in the rodent brain, with a focus on the function of nuclear receptor coactivators in hormone-dependent gene expression in brain and behavior. His lab was one of the first to show that nuclear receptor coactivators are important in estrogen receptor transcriptional activity in brain and in the modulation of hormone-dependent behaviors. Recently his NIH-funded lab has taken a proteomics-based approach to investigate protein-protein interactions between steroid receptors and nuclear receptor coactivators from brain. Dr. Tetel teaches biology and neuroscience courses, including an upper-level neuroendocrinology course and lab. Dr. Tetel is a member of the Endocrine Society, Society for Neuroscience, Society for Behavioral Neuroendocrinology and Faculty for Undergraduate Neuroscience.

Sherri-Ann Maryna Burnett-Bowie, Massachusetts General Hospital, Boston, MA

Sherri-Ann M. Burnett-Bowie, MD, MPH is an Assistant Professor at Harvard Medical School and an investigator in the Massachusetts General Hospital (MGH) Endocrine Unit, where her research focuses on defining the physiology of the mineral metabolism hormone, FGF23; skeletal and non-skeletal effects of vitamin D; and clinical trials of treatments for osteoporosis. She has received multiple local and national grants to support her clinical investigation and local awards for both excellence in teaching and the promotion of diversity and inclusion.

Nothing to Disclose: SRH, JKR, MJT, SAMB

After this session, attendees will be able to:

  • Receive information and advice on how to maximize their first years as an independent investigator and optimally prepare for a promotion and tenure application
  • Understand the similar and unique challenges of the first few years as a PI at several types of institutions
  • Use panelists’ experiences to identify ways to correct missteps made early in their careers
  • Identify strategies to optimize research productivity, personnel management, and funding as a new PI